Simmons R L, Lopez C, Balfour H, Kalis J, Rattazzi L C, Najarian J S
Ann Surg. 1974 Oct;180(4):623-34. doi: 10.1097/00000658-197410000-00028.
One-hundred thirty-two renal transplant recipients were systematically screened for viral infections and the findings correlated with the clinical course. One-hundred ten patients showed evidence of infection with herpesviruses and 89 patients showed laboratory evidence of infection with cytomegalovirus (CMV) uncomplicated by bacterial infections or technical complications. Patients without viral infections were usually asymptomatic. After recovery and development of anti-viral antibodies, most patients were asymptomatic despite the persistence of viral excretion in the urine. In contrast, the onset of viral infections were almost always accompanied by a significant clinical illness characterized by fever, leukopenia, and renal malfunction. Of 89 patients with cytomegalovirus infections, 83 survived at least three months. In these patients, the fever appeared to be self-limited and resolution of the fever was accompanied by increases in anti-CMV antibody. Renal biopsies demonstrated typical rejection reactions in all the biopsied patients and renal malfunction usually responded to anti-rejection treatment. Six of the 89 patients with CMV infections died within a month of viral isolation. These patients could be distinguished from those who recovered by a decreased or absent antibody response to the virus, suppressed lymphocyte responses to mitogen in autochthonous blood, and absent histologic evidence of rejection in the renal allografts. Thus, two paradoxical responses to CMV infections are seen in transplant patients: In the relatively immunocompetent patient, the infection is associated with renal allograft rejection, a prompt antibody response to the virus, and recovery. The severely immunosuppressed patient cannot make an antibody response, does not exhibit allograft rejection as a cause of renal malfunction, he may be further immunosuppressed by the viral infection, and is susceptible to sequential opportunistic infections leading to death.
对132例肾移植受者进行了系统的病毒感染筛查,并将结果与临床病程相关联。110例患者有疱疹病毒感染的证据,89例患者有巨细胞病毒(CMV)感染的实验室证据,且未并发细菌感染或技术并发症。无病毒感染的患者通常无症状。在产生抗病毒抗体并恢复后,大多数患者尽管尿液中持续排出病毒,但仍无症状。相比之下,病毒感染的发作几乎总是伴有以发热、白细胞减少和肾功能不全为特征的严重临床疾病。在89例巨细胞病毒感染患者中,83例存活至少3个月。在这些患者中,发热似乎是自限性的,发热消退伴随着抗CMV抗体的增加。肾活检显示所有活检患者均有典型的排斥反应,肾功能不全通常对抗排斥治疗有反应。89例CMV感染患者中有6例在病毒分离后1个月内死亡。这些患者与康复患者的区别在于对病毒的抗体反应降低或缺失、自体血中淋巴细胞对有丝分裂原的反应受抑制以及肾移植中无排斥反应的组织学证据。因此,在移植患者中可见对CMV感染的两种矛盾反应:在相对免疫功能正常的患者中,感染与肾移植排斥反应、对病毒的迅速抗体反应和康复相关。严重免疫抑制的患者无法产生抗体反应,不表现出移植排斥作为肾功能不全的原因,他可能因病毒感染而进一步免疫抑制,并且易患导致死亡的相继机会性感染。